Please Click Here to Browse the Assay List
Background of Adenosine Receptors
Adenosine receptors (AR) are a family of G-protein coupled receptor that has adenosine as its endogenous ligand and
can be found in nearly all human tissues and organs. They are known to play a role in a wide range of
physiopathological responses, including vasodilation, pain, and inflammation. In particular, adenosine acts as a
neuromodulator in the central nervous system (CNS), with varied actions depending on the type of AR and subsequent
cellular signaling involved.
Fig. 1 Structure of the human adenosine A1 receptor.1 (PDB: 5UEN)
Distribution and Function of Adenosine Receptors
AR are found in nearly every organ and tissue, including the brain, heart, lungs, liver, kidney, bone, eye, skin,
joints, and blood cells, implying that these proteins have the capacity to affect nearly every physiological
function. This wide range of locations reflects the multitude of physiological effects orchestrated by it, including
neurotransmitter inhibition, sedation, anticonvulsant, anxiolytic, analgesia, and regulation of sleep.
Subtypes and Mechanism of Adenosine Receptors
The A1, A2A, A2B, and A3 receptors are the four members of the AR family. A1 and A3 receptors inhibit adenylyl
cyclase (AC) through Gi/Go proteins, while A2A and A2B receptors stimulate it through
Gs proteins.
Receptor
|
Gene
|
Mechanism
|
Agonists
|
Antagonists
|
A1 receptor
|
ADORA1
|
-
A1 receptors activating Gi/Go proteins/AC/PLC pathway and
activation of potassium channels.
-
A1 receptors modulating mitogen-activated protein kinases (MAPK)
|
-
Adenosine
-
CCPA
-
2'-MeCCPA
-
GR 79236
|
-
Caffeine
-
Theophylline
-
CPX
-
DPCPX
-
PSB 36
|
A2A receptor
|
ADORA2A
|
-
A2A receptors coupling to Gs proteins to increase cAMP levels
-
A2A receptors activation through PKA-dependent or independent mechanisms
|
-
ATL-146e
-
CGS-21680
-
Regadenoson
-
Adenosine
|
-
Caffeine
-
Aminophylline
-
Theophylline
-
Istradefylline
-
SCH-58261
|
A2B receptor
|
ADORA2B
|
-
A2B receptors activating Gs proteins/cAMP/PKA phosphorylation pathway
-
A2B receptors stimulating an increase in Gq protein/PLC/Ca2+ pathway
|
-
BAY 60-6583
-
Adenosine
-
LUF-5835
-
LUF-5845
|
-
Theophylline
-
Caffeine
-
CVT-6883
-
MRS-1706
-
PSB-603
|
A3 receptor
|
ADORA3
|
-
A3 receptors coupling to Gi/Go proteins to decrease cAMP levels
-
A3 receptors stimulating an increase in Gq protein/PLC/Ca2+ pathway
|
-
IB-MECA
-
Adenosine
-
2-Cl-IB-MECA
-
CP-532,903
-
MRS-3558
|
-
Theophylline
-
Caffeine
-
MRS-1191
-
PSB-11
-
VUF-5574
|
Assay List of Adenosine Receptors
Creative Biolabs can provide a range of assays of adenosine receptors. You can choose the assay in the list
or contact us for more information:
ADORA1 ADORA2A ADORA2B ADORA3
Assay No.
|
Assay Name
|
Host Cell
|
Assay Type
|
Datasheet
|
cAMP Assay
|
S01YF-0722-KX1
|
Magic™ Human ADORA1 In Vitro Agonist & Antagonist cAMP Assay, HEK293
|
HEK293
|
cAMP Assay
|
|
S01YF-1122-KX154
|
Magic™ Mouse ADORA1 In Vitro cAMP Assay
|
CHO-K1
|
cAMP Assay
|
|
Calcium Flux Assay
|
S01YF-0722-KX65
|
Magic™ Human ADORA1 In Vitro Calcium Assay, HEK293-Ga15
|
HEK293-Ga15
|
Calcium Flux Assay
|
|
S01YF-1122-KX150
|
Magic™ Human ADORA1 In Vitro Calcium Flux Assay
|
CHO-K1
|
Calcium Flux Assay
|
|
β-Arrestin Assay
|
[35S]GTPγS binding Assay
|
S01YF-1122-KX155
|
Magic™ Mouse ADORA1 In Vitro [35S]GTPγS binding Assay
|
CHO-K1
|
[35S]GTPγS binding Assay
|
|
Radioligand Binding Assay
|
S01YF-1122-KX153
|
Magic™ Human ADORA1 In Vitro Radioligand Binding Assay
|
CHO-K1
|
Radioligand Binding Assay
|
|
S01YF-1122-KX156
|
Magic™ Mouse ADORA1 In Vitro Radioligand Binding Assay
|
CHO-K1
|
Radioligand Binding Assay
|
|
Assay No.
|
Assay Name
|
Host Cell
|
Assay Type
|
Datasheet
|
cAMP Assay
|
S01YF-0722-KX66
|
Magic™ Mouse ADORA2A In Vitro cAMP Assay, HEK293
|
HEK293
|
cAMP Assay
|
|
S01YF-1122-KX161
|
Magic™ Mouse ADORA2A In Vitro cAMP Assay
|
HEK293
|
cAMP Assay
|
|
Calcium Flux Assay
|
S01YF-1122-KX157
|
Magic™ Human ADORA2A In Vitro Calcium Flux Assay
|
HEK293-Gα16
|
Calcium Flux Assay
|
|
[35S]GTPγS binding Assay
|
S01YF-1122-KX159
|
Magic™ Human ADORA2A In Vitro [35S]GTPγS binding Assay
|
HEK293
|
[35S]GTPγS binding Assay
|
|
Radioligand Binding Assay
|
S01YF-1122-KX160
|
Magic™ Human ADORA2A In Vitro Radioligand Binding Assay
|
HEK293
|
Radioligand Binding Assay
|
|
S01YF-1122-KX162
|
Magic™ Mouse ADORA2A In Vitro Radioligand Binding Assay
|
HEK293
|
Radioligand Binding Assay
|
|
Assay No.
|
Assay Name
|
Host Cell
|
Assay Type
|
Datasheet
|
cAMP Assay
|
S01YF-1122-KX166
|
Magic™ Mouse ADORA2B In Vitro cAMP Assay
|
HEK293
|
cAMP Assay
|
|
Calcium Flux Assay
|
S01YF-0722-KX71
|
Magic™ Human ADORA2B In Vitro Calcium Assay, HEK293-Ga15
|
HEK293-Ga15
|
Calcium Assay
|
|
S01YF-1122-KX163
|
Magic™ Human ADORA2B In Vitro Calcium Flux Assay
|
HEK293-Gα16
|
Calcium Flux Assay
|
|
β-Arrestin Assay
|
S01YF-1122-KX165
|
Magic™ Human ADORA2B In Vitro Radioligand Binding Assay
|
HEK293
|
Radioligand Binding Assay
|
|
S01YF-1122-KX167
|
Magic™ Mouse ADORA2B In Vitro Radioligand Binding Assay
|
HEK293
|
Radioligand Binding Assay
|
|
Assay No.
|
Assay Name
|
Host Cell
|
Assay Type
|
Datasheet
|
cAMP Assay
|
S01YF-0722-KX69
|
Magic™ Mouse Adora3 In Vitro cAMP Assay, CHO-K1
|
CHO-K1
|
cAMP Assay
|
|
Calcium Flux Assay
|
S01YF-0722-KX70
|
Magic™ Human ADORA3 In Vitro Calcium Assay, HEK293-Ga15
|
HEK293-Ga15
|
Calcium Assay
|
|
S01YF-1122-KX168
|
Magic™ Human ADORA3 In Vitro Calcium Flux Assay
|
CHO-K1-Ga16
|
Calcium Flux Assay
|
|
β-Arrestin Assay
|
S01YF-0722-KX67
|
Magic™ Human ADORA3 In Vitro β-Arrestin Assay, CHO-K1-β-Arrestin
|
CHO-K1-β-Arrestin
|
β-Arrestin Assay
|
|
[35S]GTPγS binding Assay
|
S01YF-1122-KX173
|
Magic™ Mouse ADORA3 In Vitro [35S]GTPγS binding Assay
|
CHO-K1
|
[35S]GTPγS binding Assay
|
|
S01YF-1122-KX175
|
Magic™ Rat ADORA3 In Vitro [35S]GTPγS binding Assay
|
HEK293
|
[35S]GTPγS binding Assay
|
|
Radioligand Binding Assay
|
S01YF-1122-KX171
|
Magic™ Human ADORA3 In Vitro Radioligand Binding Assay
|
CHO-K1
|
Radioligand Binding Assay
|
|
S01YF-1122-KX174
|
Magic™ Mouse ADORA3 In Vitro Radioligand Binding Assay
|
CHO-K1
|
Radioligand Binding Assay
|
|
S01YF-1122-KX176
|
Magic™ Rat ADORA3 In Vitro Radioligand Binding Assay
|
HEK293
|
Radioligand Binding Assay
|
|
Published Data
Paper Title
|
Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without
cardiorespiratory depression
|
Journal
|
Nature Communications
|
Published
|
2022
|
Abstract
|
The tendency of G protein-coupled receptors (GPCRs) to connect to numerous intracellular signaling
pathways hinders the creation of therapeutic agonists for these receptors. Numerous downstream
biological implications of this promiscuous coupling are therapeutically unfavorable. Particularly true
for adenosine A1 receptors (A1Rs), whose therapeutic potential is limited by the
drowsiness and cardiorespiratory depression brought on by traditional agonists. They have found that
benzyloxy-cyclopentyladenosine (BnOCPA), an A1R-selective agonist, is a robust and effective
analgesic but does not result in drowsiness, bradycardia, hypotension, or respiratory depression. This
never-before-seen differentiation amongst native A1Rs results from BnOCPA's singular
activation of Gob among the six Gαi/o subtypes and exquisitely selective activation in the
absence of β-arrestin recruitment.
|
Result
|
They started by investigating the binding properties of BnOCPA at the hA1R using conventional
radioligand binding and a NanoBRET agonist binding assay. BnOCPA was synthesized independently as part
of a screen for potential scaffolds for the production of fluorescent ligands for the A1R.
They found that BnOCPA had an affinity for the hA1R that was higher than that of the
endogenous agonist adenosine and comparable to that of the archetypal A1R agonists CPA and NECA using
both assays. Notably, the high-affinity state of the biphasic binding profile seen in the NanoBRET
experiment was equivalent to that previously described for BnOCPA utilizing NECA-TAMRA as the
fluorescent agonist tracer.
Fig. 2 Human A1R assay.2
|
References
-
Glukhova, A.; et al. Structure of the adenosine A1 receptor reveals the basis for subtype selectivity. Cell. 2017, 168(5): 867-877. e13.
-
Wall, M.J.; et al. Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia
without cardiorespiratory depression. Nature communications. 2022, 13(1): 1-22.
Note: All of our products are for Research Use Only (RUO). NOT intended for diagnostic, therapeutic or clinical use. We DO NOT offer patients any direct products or services. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.